ResearcherSouthern Medical UniversityActive in the last 2 years
Keqiang Ma
Matched on ORCID iD 0000-0001-9617-0538; OpenAlex author ID A5083695674. Sources: PubMed.
Their work
- Papers
- 4 (first author 2, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2021: 1 paper · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 4
- Single-Cell RNA Sequencing-Integrated Fibroblast Markers and Candidate Drug-Target Associations in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1155/humu/7172433↗
- Constructing a Novel Prognostic Signature Based on TGF-β Signaling for Personalized Treatment in Pancreatic Adenocarcinoma. Last author DOI 10.1155/2022/4419119↗
- A Substance P (SP)/Neurokinin-1 Receptor Axis Promotes Perineural Invasion of Pancreatic Cancer and Is Affected by lncRNA LOC389641. First author DOI 10.1155/2022/5582811↗
- PADI1 contributes to epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma through activating ERK1/2-p38 signaling pathway First author DOI 10.21203/rs.3.rs-304683/v1↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tengfei Ji · 3 shared papers, 2021–2022 · strength 0.68
- Paper Constructing a Novel Prognostic Signature Based on TGF-β Signaling for Personalized Treatment in Pancreatic Adenocarcin… DOI 10.1155/2022/4419119↗
- Paper A Substance P (SP)/Neurokinin-1 Receptor Axis Promotes Perineural Invasion of Pancreatic Cancer and Is Affected by lncR… DOI 10.1155/2022/5582811↗
- Paper PADI1 contributes to epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma through activating ERK1/2-p3… DOI 10.21203/rs.3.rs-304683/v1↗
- Tengfei Ji · 1 shared paper, 2026 · strength 0.43
- Tiansheng Cao · 2 shared papers, 2021–2022 · strength 0.42
- Paper A Substance P (SP)/Neurokinin-1 Receptor Axis Promotes Perineural Invasion of Pancreatic Cancer and Is Affected by lncR… DOI 10.1155/2022/5582811↗
- Paper PADI1 contributes to epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma through activating ERK1/2-p3… DOI 10.21203/rs.3.rs-304683/v1↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.